ClinicalTrials.Veeva

Menu

Anxiety, Stress and Pain & Myocardial Infarction

M

Medical University of Graz

Status

Enrolling

Conditions

Myocardial Infarction

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04130269
31-478 ex 18/19 (Other Identifier)
7479

Details and patient eligibility

About

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing Posttraumatic Stress Disorder (PTSD) after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress, and PTSD after an acute myocardial infarction.

Full description

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing PTSD after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress and PTSD after an acute myocardial infarction.

Patients will be examined during three times - in the acute myocardial infarction period (Day 1-3), before dismissal (Day 5-14) and after 6 months for a follow-up. During all times they will be given questionnaires asking about their levels of stress, anxiety and general well-being as well as tests checking their cognitive abilities (thus to find out if they decrease over time). Moreover, blood samples checking cortisol levels as well as metanephrine levels will be taken in order to objectify the levels of stress that are stated by the patients. Furthermore, clinical evaluations, laboratory runs (troponin), ECGs and echocardiographies will be done at all three points in time.

The goal is to detect the biopsychosocial relations and to develop better prevention.

Enrollment

100 estimated patients

Sex

All

Ages

19 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • willingness to participate in the study
  • men and women 19-90
  • after myocardial infarctions
  • no psychiatric disease before myocardial infarction
  • no other severe disease influencing the immune system

Exclusion criteria

  • non fulfilment of inclusion criteria
  • non-compliant patients (dementia, delirium)
  • steroid-therapy

Trial design

100 participants in 1 patient group

Patients with MCI
Description:
Patients with myocardial infarction (STEMI/NSTEMI) aged 19-90
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Hans-Bernd Rothenhäusler, MD; Andreas Baranyi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems